NLRP3 and neurodegenerative disease: The results suggest that NLRP3 inhibitors such as MCC950 may be a promising therapeutic candidate for neuroinflammation and may provide new inspiration for the development of therapeutic approaches for the treatment of various neurodegenerative diseases.